Compare PGEN & COTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PGEN | COTY |
|---|---|---|
| Founded | 1998 | 1904 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.9B |
| IPO Year | 2013 | 2012 |
| Metric | PGEN | COTY |
|---|---|---|
| Price | $3.10 | $2.04 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 17 |
| Target Price | ★ $7.67 | $4.46 |
| AVG Volume (30 Days) | 3.4M | ★ 6.3M |
| Earning Date | 03-25-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $230,981,000.00 | ★ $5,892,900,000.00 |
| Revenue This Year | $342.78 | $0.19 |
| Revenue Next Year | $478.46 | $1.44 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.11 | $2.07 |
| 52 Week High | $5.47 | $5.65 |
| Indicator | PGEN | COTY |
|---|---|---|
| Relative Strength Index (RSI) | 33.67 | 23.46 |
| Support Level | $2.99 | N/A |
| Resistance Level | $5.10 | $3.43 |
| Average True Range (ATR) | 0.17 | 0.08 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 10.83 | 11.83 |
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
Coty is a global beauty maker that generates 65% of sales from prestige beauty products (primarily fragrances) and 35% from mass makeup, skin care, and fragrance. For the fragrance business, Coty licenses luxury and high-end brands including Gucci, Burberry, Hugo Boss, Davidoff, and Calvin Klein. In contrast, its consumer cosmetics business focuses on acquired mass brands such as CoverGirl, Max Factor, Rimmel, Sally Hansen, and Bourjois. It also collaborates with social media celebrity Kylie Jenner to manage makeup products bearing her name. By region, Coty generates close to 48% of sales from Europe, 40% from the Americas, and 12% from Asia-Pacific. German investment firm JAB is a controlling shareholder, with a 54% stake.